English
This article is from Indian Journal of Palliative Care , volume 17 . Abstract Introduction:: The prospective interventional single-institution randomized control study was carried out to compare the pain relieving efficacy among different bisphosphonates at the cost of incidence of skeletal-related events (SRE). Materials and Methods:: During June 2008 and May 2011, 256 patients with painful bone metastasis in solid tumors with a pain score of at least 5 were randomized into three arms: zoledronic acid (4 mg, i.v.), ibandronate (6 mg, i.v.) and pamidronate (90 mg, i.v.). Radiation was given to all patients, either 800 cGy single fraction or 20 Gy in five fractions. The ANOVA test was used for analysis. The Pearson test was used to correlate pain scores with proportions of responders as statistical estimation of pain relief. Results:: With a mean baseline pain score of 6.5 ± 1.2, there was no difference in pain scores among the three treatment arms, assessed at 3 months and at the end of the study. However, the pain scores at 6 months were statistically reduced in zoledronic acid-receiving patients (1.5 ± 0.4) unlike the scores in patients receiving ibandronate (3.1 ± 0.5) and pamid
Sign in with your free account to read, download EPUBs or listen.
Ebook · A Randomized Controlled Trial to Compare the Efficacy of Bisphosphonates in the Management of Painful Bone Metastasis. · Choudhury, Krishnangshu Bhanju, Mallik, Chandrani, Sharma, Shyam, Choudhury, Debangshu Bhanju, Maiti, Sumana, Roy, Chhaya · Internet Archive